Carisma Therapeutics is a biotechnology company developing cellular immunotherapies. Founded by Michael Klichinsky and Saar Gill in 2016, Carisma Therapeutics is backed by investors that include Agent Capital, IP Group Plc, MRL Ventures Fund, Penn Medicine, and Wellington Partners and is headquartered in Philadelphia.
FOUNDED:
2016
INDUSTRY:
Biotechnology, Health Care, Life Science, Medical, Therapeutics
FOUNDERS:
Michael Klichinsky, Saar Gill
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
